Tai Chi for Behavioral Modification Among Individuals With Metabolic Syndrome

Tai Chi Applied Behavioral Modification Program for Individuals With Metabolic Syndrome: Randomized Study

This is the randomized trial to explore the effect of behavioral modification program (Tai Chi vs. self management) on adults with metabolic syndrome. The outcome variables include health behavior, metabolic syndrome indicators, quality of life.

Study Overview

• Status: Completed
• Conditions: Metabolic Syndrome
• Intervention / Treatment: Behavioral: Tai Chi exercise; Behavioral: self management

Detailed Description

1. venue: the individuals with diagnosis of metabolic syndrome are recruiting from university hospital outpatient clinic or primary clinic.
2. inclusion criteria: diagnosed of metabolic syndrome, agree to participate either programs, no history of participating regular exercise program past 6 months.
3. intervention: The behavioral modification program consisting of Tai Chi exercise (twice a week for 12 weeks) and self-management program (6 sessions every two weeks) is provided to the participants who randomly assigned to either group. Short form Yang style Tai Chi (16 movements) were led by trained Tai Chi practitioners, and self-management program were provided by nurse educators.

• Study Type: Interventional
• Enrollment (Actual): 65
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Korea, Republic of
  • Daejeon, Korea, Republic of, 34885
    • Chungnam National University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• diagnosis of metabolic syndrome
• adults who agree to participate either behavioral modification programs for 12 weeks
• be able to understand the questionnaire and follow the exercise or education program

Exclusion Criteria:

• who attend regular exercise program past 6 months

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Tai Chi intervention; Tai Chi exercise intervention provided twice a week for one hour for 12 weeks	Behavioral: Tai Chi exercise; Yang style Tai Chi 16 movements
Active Comparator: self management; self management program provided 6 sessions (one hour per session) for 12 weeks	Behavioral: self management; health education and dietary counseling

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Cardiac health behavior scale	cardiac health behaviors scale including exercise, diet, stress management, health responsibility, and smoking - 25 items in 4 point Likert scale	change from baseline health behavior score at 3 months
Change in blood pressure	systolic and diastolic blood pressure (mmHg)	change from baseline blood pressure at 3 months
change in lipid profile	high density lipoprotein(HDL), low density lipoprotein(LDL), total cholesterol, triglyceride	change from baseline lipid profile at 3 months
Change in blood glucose	HbA1C	change from baseline blood glucose at 3 months
Change in abdominal obesity	waist circumference (in centimeters) will be measured with indicator on upper hip bone	change from baseline waist circumference at 3 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in quality of life	health related quality of life (by SF36 v.2) to calculate mental and physical components in 100 points	change from baseline QOL score at 3 months

Collaborators and Investigators

• Sponsor: Chungnam National University
• Collaborators: National Research Foundation, Singapore
• Investigators: Principal Investigator: Rhayun Song, Chungnam National University

Study record dates

Study Major Dates

• Study Start (Actual): December 10, 2020
• Primary Completion (Actual): January 28, 2022
• Study Completion (Actual): January 28, 2022

Study Registration Dates

• First Submitted: January 26, 2021
• First Submitted That Met QC Criteria: January 28, 2021
• First Posted (Actual): February 2, 2021

Study Record Updates

• Last Update Posted (Actual): March 9, 2022
• Last Update Submitted That Met QC Criteria: March 7, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Glucose Metabolism Disorders; Metabolic Diseases; Disease; Insulin Resistance; Hyperinsulinism; Syndrome; Metabolic Syndrome
• Other Study ID Numbers: ChungnamNU2

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No